M

Mabpharm Ltd
HKEX:2181

Watchlist Manager
Mabpharm Ltd
HKEX:2181
Watchlist
Price: 0.54 HKD -1.82% Market Closed
Market Cap: 2.2B HKD

Operating Margin
Mabpharm Ltd

-4%
Current
-266%
Average
-4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-4%
=
Operating Profit
-16.8m
/
Revenue
423.9m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
CN
Mabpharm Ltd
HKEX:2181
2.2B HKD
-4%
FR
Pharnext SCA
OTC:PNEXF
6T USD
-17 527%
US
Abbvie Inc
NYSE:ABBV
407.1B USD
33%
US
Amgen Inc
NASDAQ:AMGN
179.3B USD
34%
US
Gilead Sciences Inc
NASDAQ:GILD
157.2B USD
39%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
116.6B USD
39%
US
Epizyme Inc
F:EPE
94.1B EUR
-370%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.5B USD
28%
AU
CSL Ltd
ASX:CSL
85.1B AUD
26%
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
53.5B USD
8%
NL
argenx SE
XBRU:ARGX
44.2B EUR
22%
No Stocks Found

Mabpharm Ltd
Glance View

Market Cap
2.2B HKD
Industry
Biotechnology

Mabpharm Ltd. engages in the research, development, and manufacture of monoclonal antibody drugs for the treatment of cancer and autoimmune diseases. The company is headquartered in Taizhou, Jiangsu. The company went IPO on 2019-05-31. The firm's main products include omalizumab (CMAB007), cetuximab (CMAB009) and infliximab (CMAB008). The firm mainly conducts its businesses in China market.

Intrinsic Value
1.15 HKD
Undervaluation 53%
Intrinsic Value
Price
M
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-4%
=
Operating Profit
-16.8m
/
Revenue
423.9m
What is the Operating Margin of Mabpharm Ltd?

Based on Mabpharm Ltd's most recent financial statements, the company has Operating Margin of -4%.

Back to Top